Australia’s largest ketamine trial for depression underway

Evaluation of the drug is much needed as some clinics offer repeated dosage without evidence of safety, says professorThe largest randomised double-blind trial to evaluate the effectiveness of ketamine as a new treatment for depression has begun in Australia and New Zealand.Over the course of three years, researchers from the Black Dog Institute will analyse

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous NAPSA raises thousands for charity
Next Denise Brady is NT Pharmacy Assistant of the Year